[Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria]

Francisco Javier Candel González1

  • 1Servicio de Microbiología Clínica, Hospital Clínico San Carlos, Madrid, España. fj.candel@terra.es

Insights

Antimicrobial-resistant Gram-positive bacterial infections are common. Daptomycin offers an effective treatment alternative for severe infections, unlike bacteriostatic agents like linezolid and tigecycline.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Rising prevalence of antimicrobial-resistant Gram-positive bacteria (GPB) in healthcare settings.
  • Increasing microbiological cost associated with glycopeptide use, including resistance and tolerance.
  • Need for effective treatment strategies against challenging GPB infections.

Purpose:

  • To review current therapeutic options for Gram-positive bacterial infections.
  • To evaluate the efficacy and limitations of vancomycin, linezolid, tigecycline, and daptomycin.
  • To highlight daptomycin as a potent alternative for severe GPB infections.

Summary:

  • Glycopeptide use leads to resistance and tolerance issues in GPB.
  • Linezolid and tigecycline are bacteriostatic, limiting their use in severe infections.
  • Daptomycin exhibits potent early bactericidal activity and is effective against resistant strains.

Impact:

  • Provides insights into managing complex Gram-positive bacterial infections.
  • Informs clinical decision-making regarding antibiotic selection.
  • Suggests daptomycin as a valuable therapeutic option for severe and resistant infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...